DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Genes are not simply turned on or off, but instead their expression is fine-tuned to meet the needs of a cell. How genes are modulated so precisely is not well understood. The glucocorticoid receptor (GR) regulates target genes by associating with specific DNA binding sites, the sequences of which differ between genes. Traditionally, these binding sites have been viewed only as docking sites. Using structural, biochemical, and cell-based assays, we show that GR binding sequences, differing by as little as a single base pair, differentially affect GR conformation and regulatory activity. We therefore propose that DNA is a sequence-specific allosteric ligand of GR that tailors the activity of the receptor toward specific target genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This property aids in altering the chromatin structure and recruiting other cofactors, thus making the chromatin more accessible for the assembly of general transcription factors and the RNA polymerase complex at the target gene promoter33, 34.”
From Corticosteroids (2016) · cites this paper as [34]
In the citing paper
“Lastly, genome wide analyses unraveled that changes as subtle as the permutation of a single bp in GREs modifies the conformation of the liganded GR.”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA
Luisi, B. F., Xu, W. X., Otwinowski, Z., Freedman, L. P., Yamamoto, K. R., & Sigler, P. B. (1991) · Nature · doi:10.1038/352497a0 · Cited by 1,503
Self-citationMuchardt, C., & Yaniv, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06112.x · Cited by 591
Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., & Cato, A. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 522
Allosteric effects of DNA on transcriptional regulators
Lefstin, J. A., & Yamamoto, K. R. (1998) · Nature · doi:10.1038/31860 · Cited by 488
Self-citationGlucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement
Godowski, P. J., Rusconi, S., Miesfeld, R., & Yamamoto, K. R. (1987) · Nature · doi:10.1038/325365a0 · Cited by 420
Self-citationMechanism of the nuclear receptor molecular switch
NAGY, L. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.04.006 · Cited by 410
One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers
Leung, T. H., Hoffmann, A., & Baltimore, D. (2004) · Cell · doi:10.1016/j.cell.2004.08.007 · Cited by 392
Strähle, U., Klock, G., & Schütz, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.7871 · Cited by 355
Wang, J.-C., Derynck, M. K., Nonaka, D. F., Khodabakhsh, D. B., Haqq, C., & Yamamoto, K. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407008101 · Cited by 320
Self-citation
Cited by
Items 401–500 of 676
Li, F., Song, C. M., Zhang, Y., & Wu, D. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2021001 · Cited by 17
Datta, R. R., & Rister, J. (2022) · BioEssays · doi:10.1002/bies.202100191 · Cited by 21
Finding subtypes of transcription factor motif pairs with distinct regulatory roles
Bais, A. S., Kaminski, N., & Benos, P. V. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr205 · Cited by 17
“Single nucleotide changes too have been associated with the choice of cofactors and the set of target genes as in the case of the glucocorticoid receptor (16,21), NF-kB (22), Pit-1 (23), Foxa2 (24), etc.”
BackgroundRivers, C. A., Flynn, A., Qian, X., Matthews, L. C., Lightman, S. L., Ray, D. W., & Norman, M. (2009) · Endocrinology · doi:10.1210/en.2009-0346 · Cited by 22
“(14), who propose that the conformation of a short lever arm that is sensitive to differences in the sequence of DNA binding sites can mediate allosteric changes in receptor conformation and function, so allowing differential regulation of specific target genes.”
BackgroundMondol, T., Batabyal, S., Mazumder, A., Roy, S., & Pal, S. K. (2012) · FEBS Letters · doi:10.1016/j.febslet.2011.12.032 · Cited by 16
“One possible role of the conformational change is to couple the specific operator binding information to the protein–protein interactions, which may lead to higher specificity at the required sites [7].”
BackgroundOhtsuki, K., Kasahara, K., Shirahige, K., & Kokubo, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1172 · Cited by 18
“However, it is still possible that simultaneous binding of activators and promoter DNA could induce more drastic structural changes in TFIID because DNA functions not only as a docking site but also as a ligand (85,86).”
BackgroundKatsu, Y., Kohno, S., Oka, K., & Baker, M. E. (2016) · Steroids · doi:10.1016/j.steroids.2016.06.005 · Cited by 16
Chromatin Architecture and the Regulation of Nuclear Receptor Inducible Transcription
Biddie, S. C. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02079.x · Cited by 21
Chukhu, M., Dahiya, U. R., & Heemers, H. V. (2025) · Oncogene · doi:10.1038/s41388-025-03573-z · Cited by 27
“These cryoEM studies did not capture dynamic coregulator/cofactor-dependent changes in AR ’ s binding surface and context-speci fi c AR function that is consistent with the allosteric regulation of NRs by ligands and coregulators [77, 78, 80, 95, 96].”
Local elasticity of strained DNA studied by all-atom simulations
Mazur, A. K. (2011) · Physical Review E · doi:10.1103/physreve.84.021903 · Cited by 15
A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis
Díaz-Jiménez, D., Núñez, L., la Fuente, M. D., Dubois‐Camacho, K., Sepúlveda, H., Montecino, M. A., Torres, A., García-González, P. A., Chnaiderman, J., Vossenkämper, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10465-0 · Cited by 16
Lucafò, M., Bramuzzo, M., Selvestrel, D., Lozzo, P. D., Decorti, G., & Stocco, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673068 · Cited by 15
“GCs are steroid hormones that passively diffuse across plasma membranes and act by binding the GC receptor (GR) (7) which becomes able to translocate into the nucleus and binds as homodimer to DNA, in correspondence of GC-responsive elements (GREs), localized in the promoter region of target genes (8, 9).”
BackgroundBuisine, N., Grimaldi, A. G., Jonchère, V., Rigolet, M., Blugeon, C., Hamroune, J., & Sachs, L. M. (2021) · Cells · doi:10.3390/cells10092375 · Cited by 17
“The glucocorticoid receptor (GR) is preferentially found at inverted repeats with a 3 bp spacer (IR3) [77], whereas thyroid hormone receptor (THR) binding is biased toward direct repeats with a 4 bp spacer (DR4) and sometimes 6 bp (ER6) [78,79].”
Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
Lemkul, J. A., Lewis, S. N., Bassaganya-Riera, J., & Bevan, D. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123984 · Cited by 17
“Previous work on the vitamin D receptor-RXRα-DNA [27] and glucocorticoid receptor-DNA [28] complexes suggests that DNA binding impacts the conformational dynamics of the respective LBD.”
BackgroundWang, Y., Ma, N., Wang, Y., & Chen, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035159 · Cited by 15
“The crystal structure of GRDBD dimer binding to the FKBP5 gene has shown that the amino-terminal a helix in each GRDBD lies in the major groove and forms three connection sites at Lys63, Val64 and Arg68 residues with the bases of DNA [5,19,20].”
BackgroundMethodInfluentialSelective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads
Chirumamilla, C. S., Palagani, A., Kamaraj, B., Declerck, K., Verbeek, M. W. C., Oksana, R., Bosscher, K. D., Bougarne, N., Ruttens, B., Gevaert, K., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01324 · Cited by 16
“However, one limitation of our approach is that only ligand induced allosteric GR-LBD conformational changes are evaluated in the cofactor profiling, whereas additional GR-LBD-independent or allosteric control mechanisms induced by the DNA-responsive element are not taken into account, which may also contribute in DNA…”
BackgroundHua, G., Zein, N., Daubeuf, F., & Chambon, P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908258116 · Cited by 15
“Upon GC binding, the GC receptor (GR) controls the expression of target genes through 1) “direct transactivation” by direct binding to conserved “(+)GRE” DNA binding sites (DBSs) (2); 2) “direct transrepression” by binding to conserved inverted repeated (IR) negative response element “IR nGRE” DBSs (3); or 3) “tethere…”
BackgroundSterina, E., Michopoulos, V., Linnstaedt, S. D., Neylan, T. C., Clifford, G. D., Ethun, K. F., Lori, A., Wingo, A. P., ROTHBAUM, B. O., Ressler, K. J., et al. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105729 · Cited by 14
“Its sensitivity to glucocorticoids is flexible, varying by tissue and at different points in time (Meijsing et al., 2009; Yamamoto et al., 2005).”
BackgroundFoulk, M. S., Waggener, J. M., Johnson, J. M., Yamamoto, Y., Liew, G. M., Urnov, F. D., Young, Y., Lee, G., Smith, H. S., & Gerbi, S. A. (2013) · Chromosoma · doi:10.1007/s00412-012-0395-4 · Cited by 14
“The identity of the binding sequence alters the structural conformation and response to ligand in a vertebrate nuclear hormone receptor, tailoring the response of the receptor at different target genes (Meijsing et al. 2009 ).”
Yamane, T., Okamura, H., Nishimura, Y., Kidera, A., & Ikeguchi, M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja103218x · Cited by 14
Repetitive switching between DNA binding modes enables target finding by the glucocorticoid receptor
Keizer, V. I. P., Coppola, S., Houtsmuller, A. B., Geverts, B., van Royen, M. E., Schmidt, T., & Schaaf, M. J. M. (2019) · Journal of Cell Science · doi:10.1242/jcs.217455 · Cited by 16
“These DNA-binding sites, termed glucocorticoid response elements (GREs), are palindromic sequences that typically comprise two hexamers with a three-base pair spacer (Beato and Klug, 2000; Meijsing et al., 2009; Polman et al., 2013).”
BackgroundMcEwan, I. J., & Nardulli, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07011 · Cited by 15
Signaling by Nuclear Receptors
Krauss, G. (2014) · Wiley eBooks · doi:10.1002/9783527667475.ch06 · Cited by 15
RNA binding by the glucocorticoid receptor attenuates dexamethasone-induced gene activation
Lammer, N. C., Ashraf, H. M., Ugay, D. A., Spencer, S. L., Allen, M. A., Batey, R., & Wuttke, D. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-35549-y · Cited by 14
Li, D., Bao, X., Pang, J., Hu, X., Wang, L., Wang, J., Yang, Z., Xu, L., Wang, S., Weng, Q., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01082 · Cited by 15
Mismodeled purines: implicit alternates and hidden Hoogsteens
Hintze, B. J., Richardson, J. S., & Richardson, D. C. (2017) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798317013729 · Cited by 13
“Our survey uncovered a high number of potential purine flips in several crystal structures of the glucocorticoid receptor (GR) bound to DNA determined by Meijsing and coworkers (Meijsing et al., 2009).”
BackgroundThormann, V., Glaser, L. V., Rothkegel, M., Borschiwer, M., Bothe, M., Fuchs, A., & Meijsing, S. H. (2019) · Life Science Alliance · doi:10.26508/lsa.201800283 · Cited by 14
“Furthermore, studies showing GBS-specific activities (10, 27, 29) were performed using minimal promoters (SV40 or thymidine kinase), whereas we studied activation from the endogenous promoters of the GILZ and IL1R2 genes, respectively.”
InfluentialSelf-citationAwasthi, S., & Simons, S. S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.001 · Cited by 13
“This is not unexpected as the DNA sequence can affect GR activity (Meijsing et al., 2009).”
Mondol, T., Batabyal, S., & Pal, S. K. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.680035 · Cited by 12
“Similarly, recent work with glucocorticoid receptor protein (GRP) suggests that GRP bound to different target sequences has different structures leading to different functional outcomes (Meijsing et al., 2009).”
BackgroundBrandish, P. E., Anderson, K., Baltus, G. A., Bai, C., Bungard, C. J., Bunting, P. B., Byford, A. J., Chiu, C., Cicmil, M., Corcoran, H. A., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.12.031 · Cited by 12
Bray, D., Hook, H., Zhao, R. W., Keenan, J. L., Penvose, A. R., Osayame, Y., Mohaghegh, N., Chen, X., Parameswaran, S., Kottyan, L. C., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100098 · Cited by 12
“Analyzing such NCVs is currently impractical with standard ChIP-seq-based approaches, which are confined to the genotypes of available cells.”
Cell‐specific integration of nuclear receptor function at the genome
Everett, L. J., & Lazar, M. A. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1231 · Cited by 14
Bain, D. L., Connaghan, K. D., Maluf, N. K., Yang, Q., Miura, M. T., Angelis, R. W. D., DeGala, G. D., & Lambert, J. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt859 · Cited by 12
“A similar lack of correlation has been reported previously for AR, the ER isoforms and GR (11,15,16).”
InfluentialAssessing Allostery in Intrinsically Disordered Proteins With Ensemble Allosteric Model
Li, J., & Hilser, V. J. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.09.004 · Cited by 11
Timmermans, S., Verhoog, N. J. D., Looveren, K. V., Dewaele, S., Hochepied, T., Eggermont, M., Gilbert, B., Munck, A. B., Vanderhaeghen, T., Berghe, J. V., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101574 · Cited by 12
Min, J., Perera, L., Krahn, J. M., Jewell, C. M., Moon, A. F., Cidlowski, J. A., & Pedersen, L. C. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00453-17 · Cited by 16
Nonidentical function of Upc2A binding sites in the Candida glabrata CDR1 promoter
Vu, B. G., & Moye-Rowley, S. (2022) · Genetics · doi:10.1093/genetics/iyac135 · Cited by 11
Selective Coregulator Function and Restriction of Steroid Receptor Chromatin Occupancy by Hic-5
Chodankar, R., Wu, D., Gerke, D. S., & Stallcup, M. R. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1403 · Cited by 11
“mechanism of coregulator specificity of gene regulation is largely unknown but presumably involves several factors inherent to the gene itself: the specific DNA sequence to which the SR binds, which alters SR conformation and thus the complement of coregulators that it can bind and recruit (7, 8); the nearby binding o…”
BackgroundA versatile o -aminoanilide linker for native chemical ligation
Sánchez-Campillo, I., Miguel-Gracia, J., Karamanis, P., & Blanco‐Canosa, J. B. (2022) · Chemical Science · doi:10.1039/d2sc04158h · Cited by 11
Zhao, M., Wang, N., Guo, Y., Li, J., Yin, Y., Dong, Y., Zhu, J., Peng, C., Xu, T., & Liu, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206737119 · Cited by 12
“proposed that DNA is a sequence-specific allosteric ligand of GR and tailors the activity of the receptor toward specific target genes (41).”
BackgroundStructures and regulation of non-X orphan nuclear receptors: A retinoid hypothesis
Zhi, X., Zhou, X. E., Melcher, K., & Xu, H. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.06.012 · Cited by 13
Athira, K. V., Wahul, A. B., Soren, K., Das, T., Dey, S. K., Samudrala, P. K., Kumar, A., Lahkar, M., & Chakravarty, S. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.105083 · Cited by 11
White, J. T., Rives, J., Tharp, M. E., Wrabl, J. O., Thompson, E. B., & Hilser, V. J. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00079 · Cited by 11
Chan, I. H., & Privalsky, M. L. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0425 · Cited by 15
“Green, a lever arm identified in glucorticoid receptors is shown in the TR structure (40).”
BackgroundFischer, C., Metsger, M., Bauch, S., Vidal, R. O., Böttcher, M. E., Grote, P., Kliem, M., & Sauer, S. (2019) · Science Signaling · doi:10.1126/scisignal.aao5820 · Cited by 13
“For example, the expression of transcriptional inhibitors such as NR3C1 (which encodes GR that combats acute inflammation) (22) or ATF3 (whose gene product acts against chronic metabolically induced inflammation) (15) can lead to an almost complete depletion of inflammatory mediators, such as the marker proteins IL-1…”
BackgroundTambones, I., Sagar, A., Vaňková, P., Loginov, D. S., Carivenc, C., Rochel, N., Bourguet, W., Man, P., Bernadó, P., & le Maire, A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf967 · Cited by 13
The multimerization pathway of the glucocorticoid receptor
Alegre‐Martí, A., Jiménez‐Panizo, A., Lafuente, A. L., Johnson, T. A., Montoya-Novoa, I., Peralta-Moreno, M. N., Montanyà-Valluguera, P., Ponsetí-Pons, J., Abella, M., Kim, S., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1003 · Cited by 11
Hernández‐Puga, G., Navarrete‐Ramírez, P., Mendoza, A., Olvera, A., Villalobos, P., & Orozco, A. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.01.023 · Cited by 12
Ligand-Induced Allosteric Effects Governing SR Signaling
Okafor, C. D., Colucci, J. K., & Ortlund, E. A. (2019) · Nuclear Receptor Research · doi:10.32527/2019/101382 · Cited by 10
“response elements has been shown to modulate coregulator binding preferences in ER [55], GR [56], and the vitamin D receptor (VDR) [57].”
BackgroundHelabad, M. B., Volkenandt, S., & Imhof, P. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00004 · Cited by 11
“The activities of AR and GR are shown to also depend on this region (Meijsing et al., 2009; Helsen et al., 2012; Dalal et al., 2014).”
BackgroundChoudhury, S., Naiya, G., Singh, P., Lemmens, P., Roy, S., & Pal, S. K. (2016) · ChemBioChem · doi:10.1002/cbic.201500657 · Cited by 10
Enhancer RNA Expression in Response to Glucocorticoid Treatment in Murine Macrophages
Greulich, F., Bielefeld, K. A., Scheundel, R., Mechtidou, A., Strickland, B. A., & Uhlenhaut, N. H. (2021) · Cells · doi:10.3390/cells11010028 · Cited by 12
“We note here that this particular GRE motif, however, slightly diverted from the classical palindromic consensus (AGAACAnnnTGTTCT) sequence—an indication for DNA-driven determination of regulatory polarity [84,85].”
BackgroundRecent advances in understanding the molecular mechanisms regulating C. elegans transcription
Gaudet, J., & McGhee, J. D. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22246 · Cited by 15
“effect? Or do specific TFs undergo unique allosteric changes upon binding, enabling particular downstream general transcription factors (GTFs) to recruit RNA Polymerase II (Meijsing et al., 2009)? An initial step toward such mechanistic insights is to characterize the roles of the general transcription factors and par…”
BackgroundInsights on neoplastic stem cells from gel‐based proteomics of childhood germ cell tumors
Haskins, W. E., Eedala, S., Jadhav, Y. L. A., Labhan, M. S., Pericherla, V., & Perlman, E. J. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23282 · Cited by 10
“4), including those involved in apoptosis, have also been shown to be important [50].”
BackgroundTelorac, J., Prykhozhij, S. V., Schöne, S., Meierhofer, D., Sauer, S., Thomas‐Chollier, M., & Meijsing, S. H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw203 · Cited by 15
“Transient transfections were done essentially as described (12).”
Self-citationArchitecture of DNA Bound RAR Heterodimers
Rochel, N., & Moras, D. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9050-5_2 · Cited by 11
“6), the architecture of the DNA response element can also serve as an allosteric regulator of receptor function and receptor association with coregulators [4, 32, 43, 51, 61].”
BackgroundMethodNuclear hormone receptors: Allosteric switches
McEwan, I. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.035 · Cited by 11
Assaying Homodimers of NF-κB in Live Single Cells
Martin, E. W., Chakraborty, S., Presman, D. M., Tomassoni‐Ardori, F., Oh, K., Kaileh, M., Tessarollo, L., & Sung, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02609 · Cited by 9
“Such a reverse (gene to TF) action has been reported, where specific chromatin interfaces result in allosteric conformational changes of GR which impact gene-specific regulation (38).”
BackgroundStructural mechanism underlying variations in DNA binding by the androgen receptor
Lee, X. Y., Eynde, W. V., Helsen, C., Willems, H., Peperstraete, K., Block, S. D., Voet, A. R. D., & Claessens, F. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106499 · Cited by 10
“The residues at the end of the DNAs dictate the shape of the pseudo-continuous helices of the DNA [24].”
InfluentialDynamic Regulation of Steroid Hormone Receptor Transcriptional Activity by Reversible SUMOylation
Knutson, T. P., & Lange, C. A. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-416673-8.00008-3 · Cited by 10
Hidden heterogeneity of transcription factor binding sites: A case study of SF-1
Levitsky, V. G., Oshchepkov, D. Y., Klimova, N. V., Ignatieva, E. V., Vasiliev, G. V., Merkulov, V. M., & Merkulova, T. I. (2016) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2016.04.008 · Cited by 12
The nature of the GRE influences the screening for GR-activity enhancing modulators
Dendoncker, K., Timmermans, S., Looveren, K. V., Cauwer, L. D., Bosscher, K. D., & Libert, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181101 · Cited by 9
Modulation of RXR-DNA complex assembly by DNA context
Ősz, J., McEwen, A. G., Wolf, J., Poussin‐Courmontagne, P., Peluso‐Iltis, C., Chebaro, Y., Kieffer, B., & Rochel, N. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.11.008 · Cited by 10
Enguix-Riego, M. V., Cacicedo, J., León, B. D. D., Gómez, J. M. N.-G., Rivera, D. H., Pérez, M., Praena‐Fernández, J. M., Carmona, G. S., del Campo, E. R., Gordillo, M. J. O., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.03.025 · Cited by 9
Schauer, S., Callender, J., Henrich, V. C., & Spindler‐Barth, M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.01.013 · Cited by 10
Immune modulation for autoimmune disorders: evolution of therapeutics
Liebman, H. A. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.04.008 · Cited by 11
Saha, R., Dasgupta, S., Banerjee, R., Mitra-Bhattacharyya, A., Söll, D. G., Basu, G., & Roy, S. (2012) · Biochemistry · doi:10.1021/bi300221t · Cited by 9
Clarisse, D., Wesemael, K. V., Tavernier, J. H., Offner, F. C., Beck, I. M. E., & Bosscher, K. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197000 · Cited by 8
IDPs and their complexes in GPCR and nuclear receptor signaling
Guillien, M., le Maire, A., Mouhand, A., Bernadó, P., Bourguet, W., Banères, J., & Sibille, N. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.05.001 · Cited by 12
In vitro and in vivo characterization of Caenorhabditis elegans PHA‐4/FoxA response elements
Raharjo, W. H., Logan, B. C., Wen, S., Kalb, J. M., & Gaudet, J. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22359 · Cited by 9
“…different sequence preferences in vivo compared with in vitro (Huang et al., 1996), being able to bind to sequences without activating transcription (Leung et al., 2004) and exhibiting a lack of correlation between DNA binding affinity and transcriptional activation (Meijsing et al., 2009).”
BackgroundInfluentialYuan, L., Ling, C., Shoti, J., Yang, H., Nath, A., Keeler, G. D., Qing, K., & Srivastava, A. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102196 · Cited by 11
“53 It has previously been reported that U2OS cells are transduced extremely poorly by AAV2 vectors, even at very high multiplicities of infection (MOIs).”
Connaghan, K. D., Miura, M. T., Maluf, N. K., Lambert, J. R., & Bain, D. L. (2012) · Biophysical Chemistry · doi:10.1016/j.bpc.2012.12.005 · Cited by 8
“This is surprising in light of recent work suggesting that individual response elements allosterically modulate GR function [39].”
BackgroundLigands and DNA in the allosteric control of retinoid receptors function
Germain, P., Rochel, N., & Bourguet, W. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200168 · Cited by 9
“In addition to spacing and topology of the response elements, the nature of the half-site sequences in contact with the DBD also modulates DBD geometry and the interactions between the two DBDs, as shown for GR [37] and RXR homodimers [38].”
BackgroundDuplicate entries in the Protein Data Bank: how to detect and handle them
Wlodawer, A., Dauter, Z., Rubach, P., Minor, W., Jaskólski, M., Jiang, Z., Jeffcott, W., Anosova, O. D., & Kurlin, V. A. (2025) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798325001883 · Cited by 13
Blackford, J. A., Brimacombe, K. R., Dougherty, E. J., Pradhan, M., Shen, M., Li, Z., Auld, D. S., Chow, C. C., Austin, C. P., & Simons, S. S. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1069 · Cited by 8
Jiang, X., Dahlin, A., Weiss, S. T., Tantisira, K. G., & Lu, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-07565-2 · Cited by 8
A Bit Stickier, a Bit Slower, a Lot Stiffer: Specific vs. Nonspecific Binding of Gal4 to DNA
Carzaniga, T., Zanchetta, G., Frezza, E., Casiraghi, L., Vanjur, L., Nava, G., Tagliabue, G. M., Dieci, G., Buscaglia, M., & Bellini, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083813 · Cited by 10
“The overall outcome of these effects might well be described as DNA sequence-induced structural changes, as those reported for glucocorticoid receptor binding to its cognate site [45,46].”
BackgroundPecci, A., Ogara, M. F., Sanz, R. T., & Vicent, G. P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1037177 · Cited by 9
“In this sense, we have reported that hormone-activated GR adopts a dimer configuration in the nucleus of living murine mammary adenocarcinoma cells (94) and upon binding to a specific DNA binding site the GR dimer becomes a tetramer (Figure 1B iii) (5, 6).”
BackgroundPatel, A. K. M., Vilela, P., Shaik, T. B., McEwen, A. G., Hazemann, I., Brillet, K., Ennifar, E., Hamiche, A., Markov, G. V., Laudet, V., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad632 · Cited by 10
Reprogramming cells with synthetic proteins
Jauch, R., Yang, X., & Malik, V. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.145433 · Cited by 7
Lee, B. H., & Stallcup, M. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196965 · Cited by 9
Aryl hydrocarbon receptor signaling, toxicity, and gene expression responses to mono‐methylchrysenes
Alqassim, A. Y., Wilson, M. J., Wickliffe, J. K., Pangeni, D., Overton, E. B., & Miller, C. A. (2019) · Environmental Toxicology · doi:10.1002/tox.22770 · Cited by 8
“Such a mechanism explains how different glucocorticoid ligands can achieve differential signaling through glucocorticoid receptor.(32,33) Likewise, mRNA and protein expression of AhR-regulated CYP450s were similar among the different chrysene isomer treatments (Figures 4 and 5).”
BackgroundGhosh, M., Aroor, A. R., & Raghavan, M. R. (1990) · PubMed · Cited by 9
A New Approach to an Old Problem: Synthetic Biology Tools for Human Disease and Metabolism
Burrill, D. R., Boyle, P. M., & Silver, P. A. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010686 · Cited by 9
“2008), and glucocorticoid hormone (Meijsing et al. 2009).”
BackgroundDeciphering regulatory architectures of bacterial promoters from synthetic expression patterns
Pan, R. W., Röschinger, T., Faizi, K., García, H. G., & Phillips, R. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012697 · Cited by 11
Jin, H. L., Liu, Y., & Jeong, K. W. (2017) · Molecular Biology Reports · doi:10.1007/s11033-017-4106-3 · Cited by 8
Hörberg, J., & Reymer, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-43244-1 · Cited by 7
“Crystal structures support that helix 4 can exist as both folded (36, 62) and unfolded (28, 63).”
BackgroundTransient interactions modulate the affinity of NF-κB transcription factors for DNA
Li, T., Shahabi, S., Biswas, T., Tsodikov, O. V., Pan, W., Huang, D.-B., Wang, V. Y., Wang, Y., & Ghosh, G. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2405555121 · Cited by 8
“These factors often bind to an expanded repertoire of DNA sites with significant sequence variability (1–3).”
Liew, G. M., Foulk, M. S., & Gerbi, S. A. (2013) · Chromosome Research · doi:10.1007/s10577-013-9360-1 · Cited by 7
“Recently, it was shown that the conformation and activity of another steroid hormone receptor—the glucocorticoid receptor—is regulated by variations in the DNA sequences it binds to (Meijsing et al. 2009).”
BackgroundPiechota, M., Zięba, M., Borczyk, M., Gołda, S., Hajto, J., Skupio, U., Ślęzak, M., Parkitna, J. M. R., & Korostyński, M. (2025) · BMC Genomics · doi:10.1186/s12864-025-11676-w · Cited by 9
“Conversely, GR has also been reported to repress transcription through various mechanisms that include direct DNA binding, protein–protein interactions, employment of GR isoforms, and secondary, indirect molecular mechanisms [13–15].”
Mechanistic Insight on the Mode of Action of Colletoic Acid
Ling, T., Miller, D. J., Lang, W. H., Griffith, E. C., Rodriguez-Cortes, A., Ayachi, I. E., Palacios, G. F., Min, J., Miranda‐Carboni, G. A., Lee, R. E., Jr., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00187 · Cited by 6
MODER2: first-order Markov modeling and discovery of monomeric and dimeric binding motifs
Toivonen, J., Das, P. K., Taipale, J., & Ukkonen, E. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa045 · Cited by 6
“, 2001), sequence-dependent multiple binding modes of a factor (Zuo and Stormo, 2014; Fordyce et al., 2012; Meijsing et al., 2009)).”
BackgroundChauhan, G., & Heemers, H. V. (2021) · Cancers · doi:10.3390/cancers13163947 · Cited by 7
Suresh, P. S., Thakur, K. G., & Sharma, U. K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2003864 · Cited by 6
Kinetically-Defined Component Actions in Gene Repression
Chow, C. C., Finn, K. K., Storchan, G. B., Lu, X., Sheng, X., & Simons, S. S. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004122 · Cited by 6
“The DNA sequence to which the receptor is recruited, either by direct DNA binding or by tethering to another DNA-bound molecule, can often indicate the resultant activity of induction or repression respectively [11–13].”
BackgroundDeterminants of Bacteriophage 933W Repressor DNA Binding Specificity
Bullwinkle, T. J., Samorodnitsky, D., Rosati, R., & Koudelka, G. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034563 · Cited by 6
Pecci, A., Álvarez, L. D., Presman, D. M., & Burton, G. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666160118112313 · Cited by 7
Grasso, E. M., Majumdar, A. K., Wrabl, J. O., Frueh, D. P., & Hilser, V. J. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.04.017 · Cited by 6
Inhibiting the Glucocorticoid Receptor to Enhance Chemotherapy Response
Preković, S., & Zwart, W. T. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01195 · Cited by 6
Álvarez, L. D., Presman, D. M., & Pecci, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189588 · Cited by 8
Metadata
- Authors
- Meijsing, S. H., Pufall, M. A., So, A. Y., Bates, D. L., Chen, L., & Yamamoto, K. R.
- Affiliations
- University of Southern California (US)
- Corresponding author
- Meijsing, Sebastiaan H.
- Pufall, Miles A.
- Yamamoto, Keith R.
- Venue
- Science
- Published
- 2009-04-17
- Volume
- 324
- Issue
- 5925
- Pages
- 407-410
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2777810
- OpenAlex
- W2025919590
- Cited by
- 673
- References
- 24
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 18 · 2023: 23 · 2022: 31 · 2021: 31 · 2020: 25 · 2019: 36 · 2018: 38 · 2017: 50 · 2016: 40 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 58
- FWCI
- 37.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL076334)
- National Cancer Institute (R01CA020535)
- National Institute of General Medical Sciences (R01GM064642, GM-08537, T32GM008537, R01GM077320)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoid receptor, DNA binding sites, receptor conformation, transcriptional regulation, gene expression, receptor structure
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, DNA, Humans, Ligands, Models, Molecular, Mutation, Protein Conformation, Receptors, Glucocorticoid, Transcriptional Activation, Protein Structure, Secondary, Protein Structure, Tertiary, Crystallography, X-Ray, Protein Isoforms, Cell Line, Tumor, Rats, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.